News
Novo Nordisk A/S’ (NYSE:NVO) executives allegedly ignored internal warnings that the company was unprepared to launch its ...
France 24 on MSN4h
The big business behind weight-loss drugs: Global market to hit $150 billion by 2035They burst onto the scene four years ago and are taking over the pharmaceutical world. New GLP-1-based drugs like Ozempic, ...
Brandon William on MSN6h
I Trained Like a Pro Fighter for 30 DaysI survived 30 days of Muay Thai training. I’ve practiced martial arts my entire life but have never tried Muay Thai before. I want to see how far I can progress in 30 days and then test myself in a ...
LLY's non-obesity drugs like Verzenio and Taltz are fueling sales growth as investor focus stays on GLP-1 blockbusters.
To date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...
According to Regeneron, the drug is a bispecific antibody that binds to B-cell maturation antigen (BCMA) on cancerous plasma cells and CD3 on T cells, directing the immune system to attack and destroy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results